- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Invasive Cryptococcosis
Total 1263 results
-
Huashan HospitalEnrolling by invitationAntifungal Agents | Cryptococcal MeningitisChina
-
University of ZimbabweAIDS Care Research in AfricaCompletedHIV Infections | Cryptococcal MeningitisZimbabwe
-
Botswana-UPenn PartnershipUniversity of Pennsylvania; Doris Duke Charitable FoundationCompletedHIV Infections | Cryptococcal MeningitisBotswana
-
Robert Krause, MDCompletedInvasive Fungal Infection | Hematological Malignancy | Receipt of Solid Organ TransplantAustria
-
Radboud University Medical CenterCompletedCandidiasisNetherlands
-
University Hospital, CaenCompleted
-
SURGE TherapeuticsRecruitingNon-muscle-invasive Bladder CancerUnited States
-
VitadxFONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTERecruitingNon-muscle Invasive Bladder Cancer (NMIBC)France, Belgium, Spain
-
University of Alabama at BirminghamUniversity of Maryland; University Teaching HospitalRecruitingHIV/AIDS | Tuberculosis | Cryptococcosis | Hospitalization | HIV Testing | Transitions of CareZambia
-
University Hospital OstravaMunicipal Hospital Ostrava; University Hospital Olomouc; University of Ostrava; Public Health Institute Ostrava and other collaboratorsRecruitingInvasive Pulmonary Aspergillosis | Respiratory InfectionCzechia
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
Lin ChenCompletedCritical Illness | Aspergillosis, Invasive Pulmonary | Exhaled Breath Condensate | Bronchoalveolar Lavage Fluid | Respiration Failure | Sensitivity and Specificity | Respiratory Fungal InfectionChina
-
University of British ColumbiaWithdrawnBladder Cancer | High-Risk Cancer | Durvalumab | Non-muscle Invasive | TremelimumabCanada
-
Fidia Farmaceutici s.p.a.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)Italy
-
Winners ClinicCompletedFace Lift | Suspension Technique | Minimal Invasive SurgeryKorea, Republic of
-
University Hospital, Clermont-FerrandUniversity Hospital, EstaingUnknownNon Invasive Ventilation | Electrical Impedance Tomography | End Expiratory Lung Volume | End Expiratory Lung Impedance | - Critical CareFrance
-
Rambam Health Care CampusRecruitingInvasive Pulmonary Aspergillosis | Volatile Organic Compounds | Breath SamplesIsrael
-
Peking University Third HospitalRecruitingMinimal Invasive Surfactant Administration in Two Different Non-invasive Ventilation Modes to NRDS InfantsChina
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingEstrogen Receptor Positive | Ductal Breast Carcinoma In Situ | Grade 1 Invasive Breast Carcinoma | Grade 2 Invasive Breast Carcinoma | Grade 3 Invasive Breast Carcinoma | Invasive Ductal and Lobular Carcinoma In Situ | Mucinous Breast Carcinoma | Tubular Breast CarcinomaUnited States
-
CG Oncology, Inc.RecruitingBladder Cancer | Urothelial Carcinoma | Urologic Cancer | Non Muscle Invasive Bladder CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Co... and more
-
F2G Biotech GmbHIqvia Pty Ltd; ShionogiRecruitingInvasive AspergillosisUnited States, Taiwan, Belgium, Spain, Italy, Turkey, New Zealand, China, Canada, Netherlands, Australia, Brazil, Singapore, Israel, France, Thailand, Germany, Japan, Korea, Republic of, United Kingdom
-
Biosergen ASNucleus Network Ltd; Select Pharma Pty Ltd; Greenlight ClinicalRecruitingInvasive Fungal InfectionsAustralia
-
Basilea PharmaceuticaCompletedInvasive Fungal InfectionsUnited States
-
Merck Sharp & Dohme LLCCompletedInvasive AspergillosisBelgium, United States, Greece, Hungary, Israel, Italy, Korea, Republic of, Mexico, Peru, Russian Federation
-
Shandong UniversityCompletedInvasive Fungal InfectionsChina
-
Heidelberg UniversityCompletedInvasive AspergillosisAustria, Germany
-
F2G Biotech GmbHQuotient ClinicalWithdrawn
-
Astellas Pharma China, Inc.TerminatedInvasive AspergillosisChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedInvasive AspergillosisNetherlands
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
F2G Biotech GmbHQuotient ClinicalWithdrawnInvasive Aspergillosis
-
F2G Biotech GmbHQuotient ClinicalCompleted
-
F2G Biotech GmbHHammersmith Medicines ResearchCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHSimbec ResearchCompletedInvasive AspergillosisUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...CompletedInvasive AspergillosisSpain
-
University of CologneCompletedInvasive AspergillosisGermany, Belgium
-
Michael Cohen-WolkowiezCompleted
-
Seoul National University HospitalCompletedInvasive AspergillosisKorea, Republic of
-
Universitätsklinikum Hamburg-EppendorfCompletedSurvival After IPA | Risk Factors for IPAGermany
-
Northern Italy Leukemia GroupCompletedInvasive Pulmonary AspergillosisItaly
-
St. Joseph's Healthcare HamiltonNot yet recruitingNon-Invasive Ventilation
-
Southeast University, ChinaRecruitingInvasive AspergillosisChina
-
Merck Sharp & Dohme LLCApproved for marketing
-
F2G Biotech GmbHCovanceCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHBio-Kinetic Europe, Ltd.WithdrawnInvasive Aspergillosis
-
PfizerTerminatedInvasive AspergillosisSpain, United States, Singapore, Canada, Czechia, Netherlands, Poland, Thailand
-
F2G Biotech GmbHSimbecRresearch Ltd.CompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHHammersmith Medicines ResearchCompleted
-
Seoul St. Mary's HospitalUnknown